|
|
|
|
Survival Benefits of Direct-Acting Antiviral
Therapy in Patients with Decompensated Hepatitis C Cirrhosis
|
|
|
Reported by Jules Levin
EASL 2018 April 14 Paris France
W. Ray Kim1, Anu Osinusi2, Ajitha Mannalithara1,
Raul Aguilar2, Diana Brainard2
1Division of Gastroenterology and Hepatology, Stanford University School of Medicine
2Gilead Sciences, Inc.
|
|
|
|
|
|
|